21 U.S.C. § 379j–41
Definitions
United States · Title 21 — FOOD AND DRUGS · Status: effective
Cite this
- Citation
- 21 U.S.C. § 379j–41, Definitions, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/454423
- Permanent ID
ys:prov:454423@1- SHA-256
9dbff6458734b5d40ff96ca83f52574f1393c2541eeb4d9c10f2190181021445
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
For purposes of this subpart:
The term “abbreviated new drug application”—
does not include an application—
The term “active pharmaceutical ingredient” means—
a substance, or a mixture when the substance is unstable or cannot be transported on its own, intended—
The term “affiliate” means a business entity that has a relationship with a second business entity if, directly or indirectly—
The term “facility”—
means a business or other entity—
For purposes of subparagraph (A), separate buildings within close proximity are considered to be at one geographic location or address if the activities in them are—
The term “finished dosage form” means—
The term “human generic drug activities” means the following activities of the Secretary associated with generic drugs and inspection of facilities associated with generic drugs:
The issuance of—
The issuance of letters related to Type II active pharmaceutical drug master files which—
Postmarket safety activities with respect to drugs approved under abbreviated new drug applications or supplements, including the following activities:
The term “resources allocated for human generic drug activities” means the expenses for—
Legislative history
The public laws that enacted or amended this section. Tallies are for the whole bill as it passed each chamber — often an omnibus covering far more than this provision — not a vote on this section alone.
- Food and Drug Administration Safety and Innovation ActHouse: no recorded tallySenate: 96–1
- FDA Reauthorization Act of 2017House: no recorded tallySenate: 94–1